Fulgent Genetics Inc (FLGT)

Quick ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash US$ in thousands 55,144 58,042 65,111 54,677 97,473 84,076 58,348 66,172 79,506 168,770 138,780 353,069 164,894 214,877 100,461 151,461 87,426 53,031 2,431 9,302
Short-term investments US$ in thousands 202,962 155,027 246,595 251,018 326,681 383,726 400,083 805,146 773,377 749,236 376,622 725,227 770,652 255,102 676,578 258,317 344,443 50,939 18,530 61,322
Receivables US$ in thousands
Total current liabilities US$ in thousands 72,899 73,990 75,751 75,949 73,018 61,421 64,819 107,848 116,178 124,385 127,527 152,630 112,840 147,158 129,130 196,530 131,074 60,356 8,872 7,953
Quick ratio 3.54 2.88 4.11 4.03 5.81 7.62 7.07 8.08 7.34 7.38 4.04 7.06 8.29 3.19 6.02 2.09 3.29 1.72 2.36 8.88

December 31, 2024 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($55,144K + $202,962K + $—K) ÷ $72,899K
= 3.54

The quick ratio of Fulgent Genetics Inc has fluctuated over the past few years, ranging from a low of 1.72 to a high of 8.88. The quick ratio measures the company's ability to meet its short-term obligations with its most liquid assets.

In the latest quarter, the quick ratio stood at 3.54, indicating that the company had $3.54 in liquid assets available to cover each dollar of its current liabilities. This suggests that Fulgent Genetics Inc has a solid ability to meet its short-term financial obligations.

Overall, the trend in the quick ratio has shown some variability but generally indicates that the company has maintained a healthy level of liquidity to meet its short-term obligations. It is important for investors and stakeholders to continue monitoring the quick ratio to assess the company's liquidity position and financial health.